Evidence map›Paper›PMID 32165967›Full record

ArticleOpen access Macedonian journal of medical sciences2019

Awareness of Diabetic Retinopathy among Type II Diabetic Patients Attending at King Salman Armed Forced Hospital-Primary Health Care, Tabuk 2019.

Amal Mohammed Albalawi, Tahani Khalil, Reham Abdalmajeed Alimam, Ayah Suliman Albalawi

Abstract read
In one paragraph

Article in Open access Macedonian journal of medical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Amal Mohammed AlbalawiFamily Medicine Department, King Salman Armed Forces Hospital, Tabuk, Saudi Arabia.
Tahani KhalilFamily Medicine Department, King Salman Armed Forces Hospital, Tabuk, Saudi Arabia.
Reham Abdalmajeed AlimamInternal Medicine Department, King Salman Armed Forces Hospital, Tabuk, Saudi Arabia.
Ayah Suliman AlbalawiBatterjee Medical College, Jeddah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetic retinopathy refers to vascular disease of the retina that affects patients who have been diagnosed with type II diabetes mellitus. Information about DR must be spread the population, especially diabetic patients. Tools for DR screening are available and easy to access. No similar study was carried out in Tabuk to assess awareness of DR among type II diabetic patients up to our knowledge.

aimTo assess awareness of diabetic retinopathy among type II diabetic patients.

methodsA cross-sectional study carried out in Tabuk city at King Salman Armed Forced Hospital-Primary Health Care Centers among type II diabetic patients attending at the period of study (n = 382) to assess their awareness about diabetic retinopathy.

resultsOut of 382 diabetics patients, (41.4%) had DM less than 5 years, (34.8%) had DM more than 10 years, and (23.8%) had DM between 5-10 years, (30.1%) had university degree, (42.4%) considered having low income, (57.6%) were screened for DR in the past year, (18.1%) of participant think that Seeing optometrist is enough for DR diagnosis. The total knowledge score about DR with a mean ± SD of 6.4 ± 1.5, indicating poor knowledge level, where 180 (47.1%) had poor knowledge, 106 (27.7%) had moderate knowledge, and 96 (25.2%) had good knowledge.

conclusionAlmost the Awareness of Type II Diabetic Patients Attending at king Salman Armed Forced Hospital-Primary Health Care centre regarding Diabetic Retinopathy needs to be improved.

Indexed as

AwarenessDiabetes mellitusDiabeticDiabetic retinopathy

Identifiers

PMID32165967
PMCPMC7061365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.